FDA 483 - Traditional Medicinals, Inc - April 12, 2018

An FDA inspection of Traditional Medicinals Inc., a dietary supplement manufacturer in Sebastopol, revealed significant deficiencies in their quality control documentation. The firm failed to establish complete product specifications, theoretical yields in master manufacturing records, and cross-references for tests and examinations. Additionally, batch production records lacked essential information regarding equipment maintenance.